Thieno[2,3‐ <i>d</i> ]pyrimidine‐Core Compounds Show Activity against Clinically Relevant Gram‐Positive Bacteria-Reference-Cited by-同舟云学术

Thieno[2,3‐ d ]pyrimidine‐Core Compounds Show Activity against Clinically Relevant Gram‐Positive Bacteria

Published:2022-08-09 Issue:17 Volume:17 Page:
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Riabova Olga¹^ORCID,Egorova Anna¹^ORCID,Lepioshkin Alexander¹^ORCID,Li Yan²,Voigt Kerstin³,Kloss Florian²,Makarov Vadim¹^ORCID

Affiliation:

1. Laboratory of Biomedicinal Chemistry Federal Research Centre “Fundamentals of Biotechnology” of the Russian Academy of Sciences (Research Centre of Biotechnology RAS) 33-2 Leninsky Prospect 119071 Moscow Russia

2. Transfer Group Anti-infectives Leibniz Institute for Natural Product Research and Infection Biology Hans Knoell Institute Adolf-Reichwein-Straße 23 07745 Jena Germany

3. Jena Microbial Resource Collection Leibniz Institute for Natural Product Research and Infection Biology Hans Knoell Institute Adolf-Reichwein-Straße 23 07745 Jena Germany

Funder

Russian Science Foundation

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cmdc.202200207

Reference23 articles.

1. Why big pharma has abandoned antibiotics

2. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli

3. Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive Organisms

4. A comparison of telavancin and vancomycin for treatment of methicillin-resistant Staphylococcus aureus infections: A meta-analysis

5. Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection